Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4403)
All Articles published online
|
Apr 7, 2009 (publication date) through Apr 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Negro F, Alaei M. Hepatitis C virus and type 2 diabetes. World J Gastroenterol 2009; 15(13): 1537-1547 [PMID: 19340895 DOI: 10.3748/wjg.15.1537] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v15/i13/1537.htm |
| Number | Citing Articles |
| 1 |
Saikat Sen, Raja Chakraborty, Biplab De. Diabetes Mellitus in 21st Century. 2016; : 69 doi: 10.1007/978-981-10-1542-7_8
|
| 2 |
Akiko Yonekawa, Nobuyuki Shimono. Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B.1.1.529). Biology 2022; 11(3): 400 doi: 10.3390/biology11030400
|
| 3 |
Mohammad Zibaei, Saeed Bahadory, Hassan Saadati, Kumars Pourrostami, Farzaneh Firoozeh, Masoud Foroutan. Intestinal parasites and diabetes: A systematic review and meta-analysis. New Microbes and New Infections 2023; 51: 101065 doi: 10.1016/j.nmni.2022.101065
|
| 4 |
Chiara Giordanino, Simone Ceretto, Simona Bo, Antonina Smedile, Alessia Ciancio, Elisabetta Bugianesi, Rinaldo Pellicano, Sharmila Fagoonee, Elisabetta Versino, Giuseppe Costa, Daniele Arese, Marco Sacco, Mario Rizzetto, Giorgio Saracco. Type 2 diabetes mellitus and chronic hepatitis C: Which is worse? Results of a long-term retrospective cohort study. Digestive and Liver Disease 2012; 44(5): 406 doi: 10.1016/j.dld.2011.12.003
|
| 5 |
Chieko Matsui, Ikuo Shoji, Shusaku Kaneda, Imelda Rosalyn Sianipar, Lin Deng, Hak Hotta. Hepatitis C Virus Infection Suppresses GLUT2 Gene Expression via Downregulation of Hepatocyte Nuclear Factor 1α. Journal of Virology 2012; 86(23): 12903 doi: 10.1128/JVI.01418-12
|
| 6 |
Mohammed A. El Feki, Heba H. El Demellawy, Tamer Hifnawy. Prevalence and risk factors of hepatitis C virus and its association with diabetes mellitus in rural versus urban districts in the Beni-Suef Governorate, Egypt. Egyptian Liver Journal 2013; 3(2): 28 doi: 10.1097/01.ELX.0000427104.13118.0e
|
| 7 |
Shih-Yi Lin, Cheng-Li Lin, Shu-Woei Ju, I-Kuan Wang, Cheng-Chieh Lin, Chih-Hsueh Lin, Wu-Huei Hsu, Ji-An Liang, Tatsuo Kanda. Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study. PLOS ONE 2017; 12(3): e0173125 doi: 10.1371/journal.pone.0173125
|
| 8 |
F. Negro. Steatosis and insulin resistance in response to treatment of chronic hepatitis C. Journal of Viral Hepatitis 2012; 19(s1): 42 doi: 10.1111/j.1365-2893.2011.01523.x
|
| 9 |
Chieko Matsui, Lin Deng, Nanae Minami, Takayuki Abe, Kazuhiko Koike, Ikuo Shoji, Julie K. Pfeiffer. Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Hepatocyte Nuclear Factor 1α via Chaperone-Mediated Autophagy. Journal of Virology 2018; 92(13) doi: 10.1128/JVI.00639-18
|
| 10 |
Stéphanie Pascarella, Sophie Clément, Kévin Guilloux, Stéphanie Conzelmann, François Penin, Francesco Negro. Effects of hepatitis C virus on suppressor of cytokine signaling mRNA levels: Comparison between different genotypes and core protein sequence analysis. Journal of Medical Virology 2011; 83(6): 1005 doi: 10.1002/jmv.22072
|
| 11 |
Gregory Oxenkrug. Insulin Resistance and Dysregulation of Tryptophan–Kynurenine and Kynurenine–Nicotinamide Adenine Dinucleotide Metabolic Pathways. Molecular Neurobiology 2013; 48(2): 294 doi: 10.1007/s12035-013-8497-4
|
| 12 |
Julio Granados-Montiel, Joaquin Zúñiga, Jose Azocar, Edmond J. Feris, Daniel Terreros, Charles E. Larsen, Olga P. Clavijo, Alfredo Cruz-Lagunas, Derek Middleton, Chester A. Alper, Janardan P. Pandey, Edmond J. Yunis. Interaction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infection. Immunobiology 2011; 216(6): 686 doi: 10.1016/j.imbio.2010.10.006
|
| 13 |
Yasmin Saad, Abobakr Awad, Wafaa Alakel, Wahid Doss, Tahany Awad, Mahasen Mabrouk. Data mining of routine laboratory tests can predict liver disease progression in Egyptian diabetic patients with hepatitis C virus (G4) infection: a cohort study of 71 806 patients. European Journal of Gastroenterology & Hepatology 2018; 30(2): 201 doi: 10.1097/MEG.0000000000001008
|
| 14 |
Muhammad Sadik Memon, Zain Islam Arain, Farukh Naz, Madiha Zaki, Suresh Kumar, Asif Ali Burney. Prevalence of Type 2 Diabetes Mellitus in Hepatitis C Virus Infected Population: A Southeast Asian Study. Journal of Diabetes Research 2013; 2013: 1 doi: 10.1155/2013/539361
|
| 15 |
Aécio Flávio Meirelles de Souza, Fábio Heleno de Lima Pace, Júlio Maria Fonseca Chebli, Lincoln Eduardo Villela Vieira de Castro Ferreira. Insulin resistance in non-diabetic patients with chronic hepatitis C: what does it mean?. Arquivos Brasileiros de Endocrinologia & Metabologia 2011; 55(6): 412 doi: 10.1590/S0004-27302011000600008
|
| 16 |
Xiao Jing Wang, Anjana A. Pillai. Extrahepatic Manifestations of Chronic Hepatitis C Infection: a Review and Update. Current Hepatology Reports 2016; 15(3): 150 doi: 10.1007/s11901-016-0309-7
|
| 17 |
Jason Seewoodhary, Rodrigo Ville Benavides, Angela Silveira. Tropical medicine and diabetes: an integrative paradigm. Practical Diabetes 2022; 39(5): 40 doi: 10.1002/pdi.2420
|
| 18 |
Nicolas Goossens, Francesco Negro. The Impact of Obesity and Metabolic Syndrome on Chronic Hepatitis C. Clinics in Liver Disease 2014; 18(1): 147 doi: 10.1016/j.cld.2013.09.007
|
| 19 |
Fabrizio Angius, Luisa Marras, Angela Ingianni, Raffaello Pompei. Emerging and Reemerging Viral Pathogens. 2020; : 169 doi: 10.1016/B978-0-12-819400-3.00009-0
|
| 20 |
Eman I Elhawary, Gamal F Mahmoud, Mai A El-Daly, Fatma A Mekky, Gamal G Esmat, Mohamed Abdel-hamid. Association of HCV with diabetes mellitus: an Egyptian case-control study. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-367
|
| 21 |
Rania Nabil Bedair, Gehan M. Magour, Said Ahmed Ooda, Eman M. Amar, Ahmed M. Awad. Insulin receptor substrate-1 G972R single nucleotide polymorphism in Egyptian patients with chronic hepatitis C virus infection and type 2 diabetes mellitus. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-020-00069-1
|
| 22 |
Cliviany Borges da Silva, Diego Alves Vieira, Luisa Freitas de Melo, Anna Luiza Soares Chagas, Adriana Dias Gomes, César Lúcio Lopes de Faria Jr, Rosângela Teixeira, Dulciene Maria de Magalhães Queiroz, Gifone Aguiar Rocha, Maria Marta Sarquis Soares, Juliana Maria Trindade Bezerra, Luciana Diniz Silva. Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus. World Journal of Hepatology 2020; 12(4): 137-148 doi: 10.4254/wjh.v12.i4.137
|
| 23 |
Pooja Yedehalli Thimmappa, Sampara Vasishta, Kailash Ganesh, Aswathy S Nair, Manjunath B Joshi. Neutrophil (dys)function due to altered immuno-metabolic axis in type 2 diabetes: implications in combating infections. Human Cell 2023; 36(4): 1265 doi: 10.1007/s13577-023-00905-7
|
| 24 |
Francesco Negro. Mechanisms of hepatitis C virus-related insulin resistance. Clinics and Research in Hepatology and Gastroenterology 2011; 35(5): 358 doi: 10.1016/j.clinre.2011.01.011
|
| 25 |
Neven Papic, Christopher I. Maxwell, Don A. Delker, Shuanghu Liu, Bret S. E. Heale, Curt H. Hagedorn. RNA-Sequencing Analysis of 5' Capped RNAs Identifies Many New Differentially Expressed Genes in Acute Hepatitis C Virus Infection. Viruses 2012; 4(4): 581 doi: 10.3390/v4040581
|
| 26 |
Lewis W. Johnson, Ruth S. Weinstock. Diabetes Mellitus and Oral Health. 2014; : 45 doi: 10.1002/9781118887837.ch3
|
| 27 |
Sintayehu Ambachew, Setegn Eshetie, Demeke Geremew, Aklilu Endalamaw, Mulugeta Melku. Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis. Systematic Reviews 2019; 8(1) doi: 10.1186/s13643-019-0976-x
|
| 28 |
Ebtesam M. Ba-Essa, Eman I. Mobarak, Nasser M. Al-Daghri. Hepatitis C virus infection among patients with diabetes mellitus in Dammam, Saudi Arabia. BMC Health Services Research 2016; 16(1) doi: 10.1186/s12913-016-1578-0
|
| 29 |
Jiro Fujita, Futoshi Higa. 4. Diabetes Mellitus and Infectious Diseases. Nihon Naika Gakkai Zasshi 2013; 102(4): 856 doi: 10.2169/naika.102.856
|
| 30 |
Cho Naing, Joon Wah Mak, Nyunt Wai, Mala Maung. Diabetes and Infections-Hepatitis C: Is There Type 2 Diabetes Excess in Hepatitis C Infection?. Current Diabetes Reports 2013; 13(3): 428 doi: 10.1007/s11892-013-0370-3
|
| 31 |
Z. Younossi, M. Stepanova, S. Saab, G. Trimble, A. Mishra, L. Henry. The association of hepatitis C virus infection and post‐liver transplant diabetes: data from 17 000 HCV‐infected transplant recipients. Alimentary Pharmacology & Therapeutics 2015; 41(2): 209 doi: 10.1111/apt.13027
|
| 32 |
Fatima Zahra Jadid, Hajar Chihab, Hanane Salih Alj, Raouia Elfihry, Imane Zaidane, Sanaa Tazi, Wafaa Badre, Agnes Marchio, Kamal Marhoum El Filali, Mohammed Tahiri, Rachid Saile, Pascal Pineau, Sayeh Ezzikouri, Soumaya Benjelloun. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients. Infection, Genetics and Evolution 2018; 66: 1 doi: 10.1016/j.meegid.2018.08.027
|
| 33 |
Youngbok Hong, Sejong Oh. Genome-Wide Association Study of Hepatitis in Korean Populations. Genomics & Informatics 2014; 12(4): 203 doi: 10.5808/GI.2014.12.4.203
|
| 34 |
Aida Lydia, Anindia Larasati, Rino Alvani Gani, Ikhwan Rinaldi. Liver fibrosis of hepatitis C virus infection in routine hemodialysis patients in Indonesia. Medical Journal of Indonesia 2019; 28(4): 375 doi: 10.13181/mji.v28i4.3776
|
| 35 |
Toshihiko Mizuta. Can exercise be a new approach for chronic hepatitis C?. Hepatology Research 2011; 41(10): 925 doi: 10.1111/j.1872-034X.2011.00885.x
|
| 36 |
Camila Ripoll Kappel, Nélson A. Kretzmann, Mário Reis Álvares-da-Silva. IRS1 Expression in Hepatic Tissue and Leukocytes in Chronic Hepatitis C Virus Infected Patients: A Comparative Study. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/698905
|
| 37 |
Qian Wang, Jizheng Chen, Yun Wang, Xiao Han, Xinwen Chen, Ravi Jhaveri. Hepatitis C Virus Induced a Novel Apoptosis-Like Death of Pancreatic Beta Cells through a Caspase 3-Dependent Pathway. PLoS ONE 2012; 7(6): e38522 doi: 10.1371/journal.pone.0038522
|
| 38 |
Takumi Kawaguchi, Eitaro Taniguchi, Minoru Itou, Masahiro Sakata, Shuji Sumie, Michio Sata. Insulin resistance and chronic liver disease. World Journal of Hepatology 2011; 3(5): 99-107 doi: 10.4254/wjh.v3.i5.99
|
| 39 |
Marina Angel, Yelena Petrosyan, Mary-Anne Doyle, Curtis Cooper. HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01198-x
|
| 40 |
Raymond Anthony Pashun, Nicole T. Shen, Arun Jesudian. Markedly Improved Glycemic Control in Poorly Controlled Type 2 Diabetes following Direct Acting Antiviral Treatment of Genotype 1 Hepatitis C. Case Reports in Hepatology 2016; 2016: 1 doi: 10.1155/2016/7807921
|
| 41 |
Reza Taherkhani, Fatemeh Farshadpour. Epidemiology of hepatitis C virus in Iran. World Journal of Gastroenterology 2015; 21(38): 10790-10810 doi: 10.3748/wjg.v21.i38.10790
|
| 42 |
Rehab M. Ateya, Samir A. Afifi, Nagla Abd Al Monem, Amira S. Al-Karamany, Ahmed A. Bessar, Fatma Rageh, Samar S. Ahmed, Dalia Ghareeb. Impact of IL-28B gene polymorphism on chronic hepatitis-C patients progression with diabetes and non-diabetes. Egyptian Journal of Medical Human Genetics 2022; 23(1) doi: 10.1186/s43042-022-00239-3
|
| 43 |
Giorgio A. Roccaro, Robert Mitrani, Wei‐Ting Hwang, Kimberly A. Forde, K. Rajender Reddy. Sustained Virological Response Is Associated with a Decreased Risk of Posttransplant Diabetes Mellitus in Liver Transplant Recipients with Hepatitis C–Related Liver Disease. Liver Transplantation 2018; 24(12): 1665 doi: 10.1002/lt.25351
|
| 44 |
Roaid Khan, Graham R. Foster, Tahseen A. Chowdhury. Managing Diabetes in Patients with Chronic Liver Disease. Postgraduate Medicine 2012; 124(4): 130 doi: 10.3810/pgm.2012.07.2574
|
| 45 |
Dalia E. Desouky, Zaynab Kasemy, Alaa E. Abdel-Hamid, Mohamed S. Omar. Insulin Resistance and Prediabetes in Hepatitis C Virus Patients. The American Journal of the Medical Sciences 2015; 350(2): 77 doi: 10.1097/MAJ.0000000000000513
|
| 46 |
Annunziata Faustini, Paola Colais, Emanuele Fabrizi, Anna Maria Bargagli, Marina Davoli, Domenico Di Lallo, Anteo Di Napoli, Patrizio Pezzotti, Chiara Sorge, Rita Grillo, Carla Maresca, Olga Recchia, Carlo A Perucci. Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups. BMC Infectious Diseases 2010; 10(1) doi: 10.1186/1471-2334-10-97
|
| 47 |
M.A. Ibrahim, D. Sany, Y. El Shahawy, A. Awdallah. Effect of Activated Vitamin D on Glucoparameters in HCV Seropositive and Seronegative Patients on Chronic Hemodialysis. Renal Failure 2012; 34(10): 1188 doi: 10.3109/0886022X.2012.706877
|
| 48 |
Ben Niu, Lijing Ma, Lixuan Yao, Yating Zhang, Heng Su. HCV affects KATP channels through GnT-IVa-mediated N-glycosylation of GLUT2 on the surface of pancreatic β-cells leading to impaired insulin secretion. Endocrine 2023; doi: 10.1007/s12020-023-03589-z
|
| 49 |
Marco Arrese, Arnoldo Riquelme, Alejandro Soza. Insulin resistance, hepatic steatosis and hepatitis C: A complex relationship with relevant clinical implications. Annals of Hepatology 2010; 9: S112 doi: 10.1016/S1665-2681(19)31735-1
|
| 50 |
Shaimaa B. Abdelaziz, Yasmine S. Galal, Amal S. Sedrak, Dina S. Shaheen. Association of Hepatitis C Virus Infection and Type 2 Diabetes in Egypt: A Hospital-Based Study. Journal of Diabetes Mellitus 2016; 6(01): 77 doi: 10.4236/jdm.2016.61009
|
| 51 |
L I Tkachenko, V V Maleev. Insulin resistance and chronic hepatitis C. Terapevticheskii arkhiv 2016; 88(11): 29 doi: 10.17116/terarkh2016881129-36
|
| 52 |
Nabeel Alzahrani. Hepatitis C virus, insulin resistance, and diabetes: A review. Microbiology and Immunology 2022; 66(10): 453 doi: 10.1111/1348-0421.13023
|
| 53 |
Andreas Cerny. Hepatitis C after simultaneous liver–kidney transplantation. Journal of Hepatology 2009; 51(5): 839 doi: 10.1016/j.jhep.2009.08.002
|
| 54 |
Lucivalda Pereira Magalhães Oliveira, Rosangela P. de Jesus, Ramona SSB Boulhosa, Carlos Mauricio C. Mendes, Andre Castro Lyra, Luiz Guilherme C. Lyra. Metabolic syndrome in patients with chronic hepatitis C virus genotype 1 infection who do not have obesity or type 2 diabetes. Clinics 2012; 67(3): 219 doi: 10.6061/clinics/2012(03)03
|
| 55 |
Ikuo SHOJI, Lin DENG, Chieko MATSUI, Hak HOTTA. Hepatitis C virus-induced glucose metabolic disorder. Uirusu 2015; 65(2): 263 doi: 10.2222/jsv.65.263
|
| 56 |
Ashutosh S. Pareek, Yana B. Garger, Prajesh M. Joshi, Carla M. Romero, Amit K. Seth. Principles of Diabetes Mellitus. 2016; : 1 doi: 10.1007/978-3-319-20797-1_16-1
|
| 57 |
T. O. Freire, R. S. S. B. Boulhosa, L. P. M. Oliveira, R. P. de Jesus, L. N. Cavalcante, D. C. Lemaire, M. B. P. Toralles, L. G. C. Lyra, A. C. Lyra. n‐3 polyunsaturated fatty acid supplementation reduces insulin resistance in hepatitis C virus infected patients: a randomised controlled trial. Journal of Human Nutrition and Dietetics 2016; 29(3): 345 doi: 10.1111/jhn.12327
|
| 58 |
M. Ligueros‐Saylan, J. E. Foley, A. Schweizer, A. Couturier, W. Kothny. An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials. Diabetes, Obesity and Metabolism 2010; 12(6): 495 doi: 10.1111/j.1463-1326.2010.01214.x
|
| 59 |
Saeeda Fouzia Qasim, Ajmaal Jami, Paras Imran, Romana Mushtaque, Rashid Naseem Khan. Frequency of Metabolic Syndrome in Chronic Hepatitis C Patients: Findings From a Lower Middle Income Country. Cureus 2020; doi: 10.7759/cureus.11975
|
| 60 |
Kirat Gill, Hasmik Ghazinian, Richard Manch, Robert Gish. Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatology International 2016; 10(3): 415 doi: 10.1007/s12072-015-9684-3
|
| 61 |
Lohanna STRAUHS-NITSCH, Marcela Ferro CAMPIOLO, Daphne Benatti Gonçalves MORSOLETTO, Alcindo PISSAIA JUNIOR, Claudia Alexandre Pontes IVANTES. CURING HEPATITIS C WITH THE NEW DIRECT ACTING ANTIVIRALS DID NOT IMPROVE INSULIN RESISTANCE AFTER ONE YEAR. Arquivos de Gastroenterologia 2020; 57(3): 267 doi: 10.1590/s0004-2803.202000000-50
|
| 62 |
Praveen Raman Mishra, Akash Bharti, Ridhi Arora, Irfan Ahmad Mir, V. P. S. Punia. Increased Insulin Resistance in Hepatitis-C Infection—Association with Altered Hepatic Function Testing. Pathophysiology 2022; 29(3): 326 doi: 10.3390/pathophysiology29030024
|
| 63 |
Stephen D. Woodhouse, Ramamurthy Narayan, Sally Latham, Sheena Lee, Robin Antrobus, Bevin Gangadharan, Shujun Luo, Gary P. Schroth, Paul Klenerman, Nicole Zitzmann. Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro. Hepatology 2010; 52(2): 443 doi: 10.1002/hep.23733
|
| 64 |
Maria Tzefos, Jacqueline L. Olin. 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: A therapeutic controversy. Journal of Clinical Lipidology 2011; 5(6): 450 doi: 10.1016/j.jacl.2011.06.013
|
| 65 |
Sandip K. Bose, Hangeun Kim, Keith Meyer, Nathan Wolins, Nicholas O. Davidson, Ranjit Ray, B. Williams. Forkhead Box Transcription Factor Regulation and Lipid Accumulation by Hepatitis C Virus. Journal of Virology 2014; 88(8): 4195 doi: 10.1128/JVI.03327-13
|
| 66 |
Gregory Oxenkrug. Tryptophan Metabolism: Implications for Biological Processes, Health and Disease. Molecular and Integrative Toxicology 2015; : 173 doi: 10.1007/978-3-319-15630-9_8
|
| 67 |
Reyes Aparcero López, José Antonio del Campo, Manuel Romero-Gómez. Hepatitis C y síndrome metabólico. Gastroenterología y Hepatología 2010; 33(7): 530 doi: 10.1016/j.gastrohep.2009.12.008
|
| 68 |
Patrice André, Christophe Ramière, Caroline Scholtes, Claire Curtil, Vincent Lotteau. Role of nuclear receptors in hepatitis B and C infections. Clinics and Research in Hepatology and Gastroenterology 2011; 35(3): 169 doi: 10.1016/j.clinre.2011.01.001
|
| 69 |
Shashi Bala, Yaphet Tilahun, Odette Taha, Hawau Alao, Karen Kodys, Donna Catalano, Gyongyi Szabo. Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. Journal of Translational Medicine 2012; 10(1) doi: 10.1186/1479-5876-10-151
|
| 70 |
Raffaello Pompei. Advances in Microbiology, Infectious Diseases and Public Health. Advances in Experimental Medicine and Biology 2015; 901: 37 doi: 10.1007/5584_2015_5014
|
| 71 |
Mitchell L. Shiffman, Nadege T. Gunn. Impact of hepatitis C virus therapy on metabolism and public health. Liver International 2017; 37(S1): 13 doi: 10.1111/liv.13282
|
| 72 |
Silvia Fabiani, Poupak Fallahi, Silvia Martina Ferrari, Mario Miccoli, Alessandro Antonelli. Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature. Reviews in Endocrine and Metabolic Disorders 2018; 19(4): 405 doi: 10.1007/s11154-017-9440-1
|
| 73 |
Ramón Arturo Kobashi-Margáin, Ylse Gutiérrez-Grobe, Guadalupe Ponciano-Rodríguez, Misael Uribe, Nahum Méndez-Sánchez. Prevalence of type 2 diabetes mellitus and chronic liver disease: A retrospective study of the association of two increasingly common diseases in Mexico. Annals of Hepatology 2010; 9(3): 282 doi: 10.1016/S1665-2681(19)31638-2
|
| 74 |
Shira Yair-Sabag, Elchanan Nussinson, Ofir Ben-Assuli, Fahmi Shibli, Azmi Shahbari, Shira Zelber-Sagi. Retrospective study of the associations between hepatitis C virus infection and metabolic factors. World Journal of Hepatology 2016; 8(30): 1269-1278 doi: 10.4254/wjh.v8.i30.1269
|
| 75 |
Gustavo Henrique De Puy e SOUZA, Luciana Diniz SILVA, Diego Alves VIEIRA, Gifone Aguiar ROCHA, Agnaldo Soares LIMA, Paula Vieira Teixeira VIDIGAL. HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND SYSTEMIC ARTERIAL HYPERTENSION ARE ASSOCIATED WITH HEPATIC NECROINFLAMMATORY ACTIVITY IN PATIENTS WITH CHRONIC HEPATITIS C. Arquivos de Gastroenterologia 2023; 60(3): 287 doi: 10.1590/s0004-2803.230302023-03
|
| 76 |
Ludovico Abenavoli, Raffaele Capasso, Natasa Milic, Francesco Capasso. Milk thistle in liver diseases: past, present, future. Phytotherapy Research 2010; 24(10): 1423 doi: 10.1002/ptr.3207
|
| 77 |
Ebtesam M. Ba-Essa, Eman I. Mobarak, Sahar Abd Elrahman. Frequency and factors associated with hepatitis C virus infection among patients with diabetes, Dammam, KSA. Journal of the Egyptian Public Health Association 2016; 91(2): 53 doi: 10.1097/01.EPX.0000483164.17996.b8
|
| 78 |
Rahul B. Ganatra, Anish Bhatnagar, Shoshana J. Herzig. Strengthening a Study of Diabetes Progression After Statin Use. JAMA Internal Medicine 2022; 182(4): 459 doi: 10.1001/jamainternmed.2021.8353
|
| 79 |
Megumi Toyoda-Akui, Hiroaki Yokomori, Fumihiko Kaneko, Yuki Shimizu, Hajime Takeuchi, Kumiko Tahara, Tadashi Motoori, Makoto Ohbu, Masaya Oda, Toshifumi Hibi. A Case of Drug-induced Hepatic Injury Associated with Sitagliptin. Internal Medicine 2011; 50(9): 1015 doi: 10.2169/internalmedicine.50.5057
|
| 80 |
Yi-Hao Yen, Fang-Ying Kuo, Kwong-Ming Kee, Kuo-Chin Chang, Ming-Chao Tsai, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen. Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients. Digestive and Liver Disease 2019; 51(1): 142 doi: 10.1016/j.dld.2018.07.003
|
| 81 |
Po-Yuan Ke. The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions. International Journal of Molecular Sciences 2018; 19(12): 3940 doi: 10.3390/ijms19123940
|
| 82 |
Ashutosh S. Pareek, Yana B. Garger, Prajesh M. Joshi, Carla M. Romero, Amit K. Seth. Principles of Diabetes Mellitus. 2017; : 311 doi: 10.1007/978-3-319-18741-9_16
|
| 83 |
M. STEPANOVA, R. AQUINO, A. ALSHEDDI, R. GUPTA, Y. FANG, Z. YOUNOSSI. Clinical predictors of fibrosis in patients with chronic liver disease. Alimentary Pharmacology & Therapeutics 2010; 31(10): 1085 doi: 10.1111/j.1365-2036.2010.04266.x
|
| 84 |
Sintayehu Ambachew, Setegn Eshetie, Demeke Geremew, Aklilu Endalamaw, Mulugeta Melku. Prevalence of Type 2 Diabetes Mellitus among Hepatitis C Virus-Infected Patients: A Systematic Review and Meta-Analysis. Dubai Diabetes and Endocrinology Journal 2018; 24(1-4): 29 doi: 10.1159/000493945
|
| 85 |
Jean Huang, Horng-Yih Ou, James Lin, Rudruidee Karnchanasorn, Wei Feng, Raynald Samoa, Lee-Ming Chuang, Ken C. Chiu, Yury E Khudyakov. The Impact of Hepatitis B Vaccination Status on the Risk of Diabetes, Implicating Diabetes Risk Reduction by Successful Vaccination. PLOS ONE 2015; 10(10): e0139730 doi: 10.1371/journal.pone.0139730
|
| 86 |
Mona Abdel Raouf, Zeinab A. Yousry, Olfat M. Hindy, Somayh S. Eissa, Dalia S. Soliman. Study of diabetes mellitus among patients with hepatitis C virus. The Egyptian Journal of Internal Medicine 2012; 24(1): 17 doi: 10.7123/01.EJIM.0000415588.62804.fc
|
| 87 |
Gowtham A. Rao, Prashant K. Pandya. Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C. Gastroenterology 2011; 140(1): 144 doi: 10.1053/j.gastro.2010.08.055
|
| 88 |
Anurag Maheshwari, Paul J. Thuluvath. Endocrine Diseases and the Liver. Clinics in Liver Disease 2011; 15(1): 55 doi: 10.1016/j.cld.2010.09.008
|
| 89 |
M. Stepanova, B. Lam, Y. Younossi, M. K Srishord, Z. M. Younossi. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity. Journal of Viral Hepatitis 2012; 19(5): 341 doi: 10.1111/j.1365-2893.2011.01554.x
|
| 90 |
Mohamed Hassan, Denis Selimovic, Abdelouahid El-Khattouti, Hanan Ghozlan, Youssef Haikel, Ola Abdelkader. Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies. World Journal of Experimental Medicine 2012; 2(2): 7-25 doi: 10.5493/wjem.v2.i2.7
|
| 91 |
Nauman A Jadoon, Mohammad A Shahzad, Rehan Yaqoob, Mansoor Hussain, Naseema Ali. Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association. Virology Journal 2010; 7(1) doi: 10.1186/1743-422X-7-304
|
| 92 |
Peter Ferenci. Safety and efficacy of treatment for chronic hepatitis C with a focus on pegylated interferons: the backbone of therapy today and in the future. Expert Opinion on Drug Safety 2011; 10(4): 529 doi: 10.1517/14740338.2011.555079
|
| 93 |
Luciana Rodrigues da CUNHA, Maria Carolina Magalhães de CASTRO, Gabriela Silva DUARTE, Graziela Cançado e NASCIMENTO, Gifone Aguiar ROCHA, Luciana Diniz SILVA. MAJOR DEPRESSIVE DISORDER IS ASSOCIATED WITH TYPE 2 DIABETES IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION. Arquivos de Gastroenterologia 2021; 58(4): 476 doi: 10.1590/s0004-2803.202100000-86
|
| 94 |
Xuan Guo, Min Jin, Ming Yang, Ke Liu, Jun-wen Li. Type 2 Diabetes Mellitus and the Risk of Hepatitis C Virus Infection: A systematic review. Scientific Reports 2013; 3(1) doi: 10.1038/srep02981
|
| 95 |
Elizabeth M. Kiefer, Qiuhu Shi, Donald R. Hoover, Robert Kaplan, Russell Tracy, Michael Augenbraun, Chenglong Liu, Marek Nowicki, Phyllis C. Tien, Mardge Cohen, Elizabeth T. Golub, Kathryn Anastos. Association of Hepatitis C With Markers of Hemostasis In HIV-Infected and Uninfected Women in the Women's Interagency HIV Study (WIHS). JAIDS Journal of Acquired Immune Deficiency Syndromes 2013; 62(3): 301 doi: 10.1097/QAI.0b013e31827fdd61
|
| 96 |
Parviz Saleh, Airin Sheikholeslami, Aida Salman Mohajer, Sara Babapour, Mohammad-Salar Hosseini. Association between Different Hepatitis C Virus Genotypes Infection and Type-2 Diabetes Mellitus: A Descriptive-Analytical Study from the Northwest of Iran. Journal of Medical Microbiology and Infectious Diseases 2020; 8(4): 137 doi: 10.29252/JoMMID.8.4.137
|
| 97 |
Fatemeh Farshadpour, Reza Taherkhani, Mohammad Reza Ravanbod, Seyed Sajjad Eghbali. Prevalence and Genotype Distribution of Hepatitis C Virus Infection among Patients with Type 2 Diabetes Mellitus. Medical Principles and Practice 2018; 27(4): 308 doi: 10.1159/000488985
|
| 98 |
Antonella Meloni, Laura Pistoia, Maria Rita Gamberini, Anna Spasiano, Liana Cuccia, Massimo Allò, Giuseppe Messina, Valerio Cecinati, Calogera Geraradi, Rosamaria Rosso, Cristina Vassalle, Riccardo Righi, Stefania Renne, Massimiliano Missere, Vincenzo Positano, Alessia Pepe, Filippo Cademartiri, Paolo Ricchi. The impact of HCV chronic positivity and clearance on extrahepatic morbidity in thalassemia major patients: an observational study from MIOT Network. European Journal of Internal Medicine 2023; 114: 93 doi: 10.1016/j.ejim.2023.05.005
|
| 99 |
Chieko Matsui, Imelda Rosalyn Sianipar, Nanae Minami, Lin Deng, Hak Hotta, Ikuo Shoji. A single-amino-acid mutation in hepatitis C virus NS5A disrupts physical and functional interaction with the transcription factor HNF-1α.
Journal of General Virology
2015; 96(8): 2200 doi: 10.1099/vir.0.000179
|
| 100 |
Zei‐Shung Huang, Tien‐Shang Huang, Tzy‐Haw Wu, Ming‐Fong Chen, Ching‐Sheng Hsu, Jia‐Horng Kao. Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: A ten‐year observation. Journal of Gastroenterology and Hepatology 2010; 25(8): 1420 doi: 10.1111/j.1440-1746.2010.06268.x
|
| 101 |
Driton Vela, Ramadan B. Sopi, Mitko Mladenov. Low Hepcidin in Type 2 Diabetes Mellitus: Examining the Molecular Links and Their Clinical Implications. Canadian Journal of Diabetes 2018; 42(2): 179 doi: 10.1016/j.jcjd.2017.04.007
|
| 102 |
Solomon Ali, Solomon Abera, Adane Mihret, Tamrat Abebe. Association of Hepatitis C Virus Infection with Type II Diabetes in Ethiopia: A Hospital-Based Case-Control Study. Interdisciplinary Perspectives on Infectious Diseases 2012; 2012: 1 doi: 10.1155/2012/354656
|